Progesterone antagonist and selective progesterone modulator...

Details Progesterone antagonist and selective progesterone modulator... Progesterone antagonist and selective progesterone modulator...

A - Human Necessities

61

K

A61K 31/567 (2006.01) A61K 31/57 (2006.01) A61P 5/36 (2006.01) A61P 7/02 (2006.01)

Patent

CA 2684450

Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last from 1 day to 180 days.

La présente invention concerne un antagoniste de la progestérone et un modulateur sélectif des récepteurs de la progestérone (SPRM) qui sont utiles pour la préparation d'un médicament destiné au traitement ou à la prophylaxie de l'hémorragie utérine excessive chez les femmes souffrant de troubles de la coagulation spontanés ou iatrogènes tels qu'une thrombopénie, une déficience en facteurs de coagulation ou en cours de traitement anti-coagulant. La durée du traitement variera de 1 jour à 180 jours.

Affiliated with

Also associated with

Rating

Progesterone antagonist and selective progesterone modulator... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Progesterone antagonist and selective progesterone modulator..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Progesterone antagonist and selective progesterone modulator... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1883130